Aurobindo Pharma's arm Eugia Pharma gets USFDA approval for Amphotericin B Liposome for Injection

The product is expected to be launched by Q4 FY23.

Related Keywords

Taiwan ,Eugia Pharma ,Ambisome Liposome ,Eugia Pharma Specialities ,Biopharm Company ,Astellas Pharma Us Inc ,Aurobindo Pharma ,Us Food Drug Administration ,Eugia Pharma Speciality Group ,Aurobindo Pharma Limited ,Eugia Pharma Specialities Limited ,Drug Administration ,Amphotericinb Liposome ,Single Dose Vial ,Astellas Pharma ,Company Limited ,